FindTrial
Sign In

To study the improvement of ischemic moderate mitral regurgitation after coronary artery bypass grafting only and not mitral valve replacement.

Outcome of moderate mitral regurgitation in coronary artery disease patients undergoing elective coronary artery bypass grafting without mitral valve replacement.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/05/042900
Enrollment
70
Registered
2022-05-30
Start date
Unknown
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I340- Nonrheumatic mitral (valve) insufficiency

Interventions

Intervention1: Not applicable: Not applicable

Sponsors

fortis escorts heart institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with moderate mitral regurgitation and coronary artery disease undergoing elective coronary artery bypass grafting. Patients with informed written consent.

Exclusion criteria

Exclusion criteria: Patients with mitral regurgitation due to rheumatic, infectious, degenerative, congenital, papillary muscles rupture, elongated chordae tendineae. Patients not giving informed consent.

Design outcomes

Primary

MeasureTime frame
improvement in mitral regurgitation after coronary artery bypass grafting.Timepoint: 12 weeks—

Secondary

MeasureTime frame
study icu stay, hospital astay, ventilation time, respiratory renal and cardial dysfunction.Timepoint: 2 weeks—

Countries

India

Contacts

Public ContactKumar Ujjwal

Fortis escorts heart institute

zile.meharwal@fortishealthcare.com9810149301

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026